Siva Therapeutics

About:

Siva Therapeutics is a biotechnology company developing nanotechnology approaches for treating cancer.

Website: https://www.sivatherapeutics.com

Top Investors: The Thiel Foundation, Breakout Labs, Texas A&M Innovation, Boston Harbor Angels

Description:

Siva Therapeutics develops cancer therapies that improve patient outcomes. They develop safe, minimally-invasive, practical, and cost-effective medical device treatments for cancer using proprietary technologies. The company's therapy generates therapeutic heat within solid tumors using gold nanorods and an infrared light device which is more selective than chemotherapy, less destructive than radiation, and without the risks of surgery.

Total Funding Amount:

$2.56M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Texas, South Carolina, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)sivatherapeutics.com

Founders:

Len Pagliaro, Stephen P. Kregstein

Number of Employees:

1-10

Last Funding Date:

2017-08-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai